Walleye Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,137
| Closed | -$48.7K | – | 2536 |
|
|
2024
Q2 | $48.7K | Sell |
28,137
-49,299
| -64% | -$85.3K | ﹤0.01% | 2159 |
|
|
2024
Q1 | $185K | Sell |
77,436
-22,619
| -23% | -$54.1K | ﹤0.01% | 1841 |
|
|
2023
Q4 | $333K | Buy |
100,055
+58,102
| +138% | +$193K | ﹤0.01% | 1318 |
|
|
2023
Q3 | $157K | Buy |
41,953
+21,299
| +103% | +$79.7K | ﹤0.01% | 1557 |
|
|
2023
Q2 | $88.2K | Buy |
+20,654
| New | +$88.2K | ﹤0.01% | 1501 |
|
|
2023
Q1 | – | Sell |
-16,467
| Closed | -$130K | – | 2213 |
|
|
2022
Q4 | $130K | Buy |
+16,467
| New | +$130K | ﹤0.01% | 1481 |
|